Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China

Zhilin Zeng,Haijing Yu,Huilong Chen,Weipeng Qi,Liang Chen,Guang Chen,Weiming Yan,Tao Chen,Qin Ning,Meifang Han,Di Wu,Zhilin Zeng,Haijing Yu,Huilong Chen,Weipeng Qi,Liang Chen,Guang Chen,Weiming Yan,Tao Chen,Qin Ning,Meifang Han,Di Wu
DOI: https://doi.org/10.1186/s13054-020-03255-0
IF: 15.1
2020-08-27
Critical Care
Abstract:Abstract Background Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease and rapidly escalating epidemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The pathogenesis of COVID-19 remains to be elucidated. We aimed to clarify correlation of systemic inflammation with disease severity and outcomes in COVID-19 patients. Methods In this retrospective study, baseline characteristics, laboratory findings, and treatments were compared among 317 laboratory-confirmed COVID-19 patients with moderate, severe, or critically ill form of the disease. Moreover, the longitudinal changes of serum cytokines, lactate dehydrogenase (LDH), high-sensitivity C-reactive protein (hsCRP), and hsCRP to lymphocyte count ratio (hsCRP/L) as well as their associations with disease severity and outcomes were investigated in 68 COVID-19 patients. Results Within 24 h of admission, the critically ill patients showed higher concentrations of inflammatory markers including serum soluble interleukin (IL)-2 receptor, IL-6, IL-8, IL-10, tumor necrosis factor alpha (TNF-α), ferritin, procalcitonin, LDH, hsCRP, and hsCRP/L than patients with severe or moderate disease. The severe cases displayed the similar response patterns when compared with moderate cases. The longitudinal assays showed the levels of pro-inflammatory cytokines, LDH, hsCRP, and hsCRP/L gradually declined within 10 days post admission in moderate, severe cases or those who survived. However, there was no significant reduction in cytokines, LDH, hsCRP, and hsCRP/L levels in critically ill or deceased patients throughout the course of illness. Compared with female patients, male cases showed higher serum concentrations of soluble IL-2R, IL-6, ferritin, procalcitonin, LDH, and hsCRP. Multivariate logistic regression analysis revealed that IL-6 > 50 pg/mL and LDH > 400 U/L on admission were independently associated with disease severity in patients with COVID-19. Conclusion Exuberant inflammatory responses within 24 h of admission in patients with COVID-19 may correlate with disease severity. SARS-CoV-2 infection appears to elicit a sex-based differential immune response. IL-6 and LDH were independent predictive parameters for assessing the severity of COVID-19. An early decline of these inflammation markers may be associated with better outcomes.
critical care medicine
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the longitudinal changes of inflammatory parameters in COVID - 19 patients and their relationship with disease severity and prognosis. Specifically, the study aims to: 1. **Clarify the correlation between systemic inflammation and disease severity and prognosis in COVID - 19 patients**: By comparing the baseline characteristics, laboratory test results and treatment situations of COVID - 19 patients with different severities (mild, moderate, severe, critical), and analyzing the longitudinal changes of serum cytokines, lactate dehydrogenase (LDH), high - sensitivity C - reactive protein (hsCRP) and the ratio of hsCRP to lymphocyte count (hsCRP/L) in these patients. 2. **Evaluate the effectiveness of specific inflammatory markers as predictors of disease severity**: Through multivariate logistic regression analysis, determine which inflammatory markers (such as IL - 6 and LDH) can independently predict the severity of the disease. 3. **Explore the impact of gender on the immune response**: Analyze the differences in the levels of inflammatory markers between male and female patients to understand whether gender affects the intensity and pattern of the immune response. Through these research objectives, the paper hopes to provide more scientific basis for understanding the immunopathological mechanism of COVID - 19 and valuable references for clinicians to evaluate and manage COVID - 19 patients.